EFCAB3
EF-hand calcium-binding domain-containing protein 3
Also known as: EFCB3_HUMAN, FLJ25818
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N7B9
- Gene
- EFCAB3
- Ensembl
- ENSG00000172421
- Chromosome
- 17
- Canonical length
- 438 aa
- Protein class
- Predicted intracellular proteins, Transporters
OverviewNCBI Gene
Predicted to enable calcium ion binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
438 residues, UniProt reviewed canonical sequence.
>Q8N7B9|EFCAB3
1 MAVSEIKPKL KLNPLTKVPI SHNKRDRDLP GSLQCQLQHK EKKLSASQMA AFQDAYNFFY
61 KDKTGCIDFH GLMCTVAKLG MNLTKHDVYN ELKCADIDRD GKVNFSDFIK VLTDKNLFLK
121 AVVPEKETCL DLAGNPGILL FEILSRLLET SALPRKSIIE IVSYFQRKFQ HTGPGMLWSP
181 YTMGYGKRTL KPDICTPPSS SMAAFANAAR IAIMKEKDLF KFLEELKRCN SGSDSPYSKI
241 PIFPLFPNVD GVVMGKPFKD MQKLEMLRIK EPLHFFEDYF FHKRDWKTQA ANIKSMDPAS
301 GYSNNIFTID QMLKKKQTCT VADATAIKQH VKRATDTYNL GIALEHRKEM LNLWQKIRGD
361 LIGMDSRNES FYDTFSTYTW SWNVCQELLS PKDLRLYDAY VNRNSSHNSR SSSSSDTSEC
421 YTDSGRKRKR KGLKGFQQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EFCAB3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 5.5 nTPM
Expression across tissuesHPA
Tissue
- testis: 5.5 nTPM
- adipose tissue: 0.4 nTPM
- retina: 0.2 nTPM
- esophagus: 0.1 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
Single-cell type
- early spermatids: 139 nCPM
- late primary spermatocytes: 31 nCPM
- late spermatids: 9.6 nCPM
- papillary tip epithelial cells: 7.7 nCPM
- undifferentiated spermatogonia: 4 nCPM
- podocytes: 3.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 0.4 nTPM
- cerebellum: 0.2 nTPM
- cerebral cortex: 0.2 nTPM
- pons: 0.2 nTPM
- amygdala: 0.1 nTPM
- basal ganglia: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.76
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EFCAB3 as an antibody target. Whether an autoantibody or antibody against EFCAB3 could matter depends on whether native EFCAB3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EFCAB3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EFCAB3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...